Real-world use of nirmatrelvir-ritonavir: who benefits?

被引:1
|
作者
Molina, Kyle C. [1 ,2 ]
Ginde, Adit A. [1 ]
机构
[1] Colorado Univ, Dept Emergency Med, Sch Med, Aurora, CO 80045 USA
[2] Scripps Hlth, La Jolla, CA 92037 USA
来源
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 07期
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1473-3099(23)00180-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:765 / 767
页数:3
相关论文
共 50 条
  • [1] Real-world use of nirmatrelvir-ritonavir: who benefits? (VOL 23, pg e122, 2023)
    Molina, K. C.
    Ginde, A. A.
    [J]. LANCET INFECTIOUS DISEASES, 2023, 23 (05): : E166 - E166
  • [2] Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19
    Zeng, Guangting
    Wang, Linlin
    Li, Jianqiang
    Zhang, Zanling
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [3] Determining and Comparing the Real-World Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19
    Jang, Young Rock
    Oh, Yoonju
    Kim, Jin Yong
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (06)
  • [4] Nirmatrelvir-ritonavir and simvastatine
    Legeay, Samuel
    Faure, Sebastien
    [J]. ACTUALITES PHARMACEUTIQUES, 2023, 62 (630): : 17 - 19
  • [5] Benefits of nirmatrelvir-ritonavir remain unproven for some populations
    McDonald, Emily G.
    Lee, Todd
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (29) : E1041 - E1041
  • [6] Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients
    Kim, Min-Kyung
    Lee, Kyung-Shin
    Ham, Sin Young
    Choi, Youn Young
    Lee, Eunyoung
    Lee, Seungjae
    Lee, Bora
    Jeon, Jaehyun
    Chin, Bumsik
    Kim, Yeonjae
    Kim, Gayeon
    Jang, Hee -Chang
    Choi, Jae-Phil
    Park, Sang -Won
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (35)
  • [7] Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study
    Deng, Guangtong
    Li, Daishi
    Sun, Yuming
    Jin, Liping
    Zhou, Qian
    Xiao, Chenggen
    Wu, Qingrong
    Sun, Huiyan
    Dian, Yating
    Zeng, Furong
    Pan, Pinhua
    Shen, Minxue
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [8] Nirmatrelvir-ritonavir for COVID-19
    McDonald, Emily G.
    Lee, Todd C.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (06) : E218 - E218
  • [9] Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study
    Qinqin Zhao
    Bei Zheng
    Bing Han
    Pinpin Feng
    Zhongni Xia
    Hong Jiang
    Yin Ying
    Jun Zhu
    Cheng Fei
    Junlei Xiang
    Lingli Shen
    Qiliang Luo
    Yinhuan Wu
    Ayiguzhali Wusiman
    Chuanwei Xin
    Meiling Zhang
    Gonghua Li
    Xiang Li
    [J]. Infectious Diseases and Therapy, 2023, 12 : 2087 - 2102
  • [10] Impact of Nirmatrelvir-Ritonavir on Tacrolimus Concentrations
    Fredrick, S.
    Wise, B.
    Bowman, L.
    DeWolfe, D.
    Taylor, J.
    Melaragno, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 787 - 788